Multiparametric magnetic resonance imaging-informed prostate biopsy is attracting increasing interest among practicing urologists.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Whether this will become the new gold standard in prostate cancer diagnosis and supplant systematic transrectal ultrasound-guided sampling remains to be determined. Here we present the main open questions and current concerns regarding this new approach.
Eur Urol. 2015 Jun 9. pii: S0302-2838(15)00455-8. doi: 10.1016/j.eururo.2015.05.049. [Epub ahead of print]
Giannarini G1, Briganti A2, Crestani A3, Rossanese M3, Montorsi F2, Ficarra V4.
1 Urology Unit, Academic Medical Centre Hospital Santa Maria della Misericordia, Udine, Italy.
2 Division of Oncology/Urology Unit, Urological Research Institute, Ospedale San Raffaele, Milan, Italy.
3 Urology Unit, Academic Medical Centre Hospital Santa Maria della Misericordia, Udine, Italy.
4 Urology Unit, Academic Medical Centre Hospital Santa Maria della Misericordia, Udine, Italy; Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy.